Showing results (41-50 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|December 14, 2020
A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene)Sean DeAngelo, Kailyn I Mann, Muhammad Abdulbasit, et al.Cardio-Oncology (London, England)|September 18, 2018
Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markersAndrew Poklepovic, Yuesheng Qu, Molly Dickinson, et al.Cardio-Oncology (London, England)|June 22, 2021
A new classification of cardio-oncology syndromesRudolf A de Boer, Joseph Pierre Aboumsallem, Valentina Bracun, et al.Cardio-Oncology (London, England)|June 1, 2021
Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapyMichael G Fradley, Mohammed Alomar, Marcus W Kilpatrick, et al.Cardio-Oncology (London, England)|July 7, 2021
Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective reviewShingo Kazama, Ryota Morimoto, Yuki Kimura, et al.Cardio-Oncology (London, England)|July 21, 2020
The hypertensive effect of sorafenib is abolished by sildenafilHubert Dabiré, Fatou Dramé, Nelly Cita, et al.Cardio-Oncology (London, England)|April 7, 2021
Etiology and management of hypertension in patients with cancerTurab Mohammed, Meghana Singh, John G Tiu, et al.Cardio-Oncology (London, England)|August 11, 2020
Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin's lymphoma: a systematic reviewYaser Khalid, Michael Fradley, Neethi Dasu, et al.Cardio-Oncology (London, England)|April 3, 2023
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory studyDae Hyun Lee, Sanjay Chandrasekhar, Michael D Jain, et al.Cardio-Oncology (London, England)|March 27, 2024
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept studyMassimiliano Camilli, Marcello Viscovo, Tamara Felici, et al.Pageof 45